Literature DB >> 6823836

Clinical follow-up study of paroxysmal supraventricular tachyarrhythmias after operative repair of a secundum type atrial septal defect in adults.

R O Brandenburg, D R Holmes, R O Brandenburg, D C McGoon.   

Abstract

Adults with isolated secundum atrial septal defect (ASD) may present with paroxysmal atrial tachyarrhythmias. The clinical course of these rhythmic disturbances after correction of the ASD is unknown. Of 188 patients aged 44 years old or older with isolated ASD, 27 (14%) (mean age 52.7 years, range 44 to 71) had documented paroxysmal atrial tachyarrhythmias preoperatively: 16 had paroxysmal atrial fibrillation, 2 had atrial flutter, and 9 had supraventricular tachycardia. Among these 3 groups, there were no differences in age, sex, New York Heart Association class, duration of preoperative symptoms, mean right atrial and pulmonary arterial pressures, shunt size, atrial size, or follow-up period. After operative repair, follow-up data were available in all patients for a mean of 12 years (range 1.5 to 25). Of the 16 patients with preoperative paroxysmal atrial fibrillation, 14 (88%) continued to have increasingly frequent paroxysmal atrial fibrillation, culminating in sustained atrial fibrillation. In 1 of the 2 patients with paroxysmal atrial flutter, sustained atrial fibrillation developed. Of the 9 patients with preoperative paroxysmal supraventricular tachycardia, 5 had no further episodes of this arrhythmia postoperatively.

Entities:  

Mesh:

Year:  1983        PMID: 6823836     DOI: 10.1016/s0002-9149(83)80048-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Analysis of P wave and P dispersion in children with secundum atrial septal defect.

Authors:  T F Ho; E L Chia; W C Yip; K Y Chan
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Sir Thomas Lewis redivivus: from pebbles in a quiet pond to autonomic storms.

Authors:  T N James
Journal:  Br Heart J       Date:  1984-07

Review 3.  [Arrhythmias in patients with congenital heart disease and their impact on prognosis].

Authors:  J Hebe; G Krings; P Hansen; M Volkmer; F Ouyang; K H Kuck
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

4.  Maximum p wave duration and p wave dispersion in adult patients with secundum atrial septal defect: the impact of surgical repair.

Authors:  Umit Guray; Yesim Guray; Burcu Mecit; M Birhan Yilmaz; Hatice Sasmaz; Sule Korkmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

5.  Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults.

Authors:  Mehmet G Kaya; Ali Baykan; Ali Dogan; Tugrul Inanc; Ozgur Gunebakmaz; Orhan Dogdu; Kazim Uzum; Namik K Eryol; Nazmi Narin
Journal:  Pediatr Cardiol       Date:  2010-01-19       Impact factor: 1.655

6.  Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients.

Authors:  C K Silversides; S C Siu; P R McLaughlin; K L Haberer; G D Webb; L Benson; L Harris
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

7.  Prediction of early-onset atrial tachyarrhythmia after successful trans-catheter device closure of atrial septal defect.

Authors:  Kyoung-Min Park; Jin Kyung Hwang; Kwang Jin Chun; Seung-Jung Park; Young Keun On; June Soo Kim; Seung Woo Park; I-Seok Kang; Jinyoung Song; June Huh
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 8.  Interatrial shunt devices for heart failure with normal ejection fraction: a technology update.

Authors:  Joseph J Cuthbert; Pierpaolo Pellicori; Andrew L Clark
Journal:  Med Devices (Auckl)       Date:  2017-06-02

9.  Efficacy of the maze procedure for atrial fibrillation associated with atrial septal defect.

Authors:  Hunbo Shim; Ji-Hyuk Yang; Pyo-Won Park; Dong Seop Jeong; Tae-Gook Jun
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-04-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.